Patient Guide: A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 90 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06819891
Status: 🟢 Enrolling Now
Condition: Moderately to Severely Active Crohns Disease
Phase: PHASE3

Where You Can Participate

This study is available at 90 locations across the country.

Top locations include:
  • • Lancaster, California
  • • Santa Clarita, California
  • • Colorado Springs, Colorado
  • • And 87 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease - Join Clinical Trial NCTNCT06819891

How to Join This Clinical Trial - NCTNCT06819891

Learn how to participate in this PHASE3 trial studying an investigational therapy for Moderately to Severely Active Crohns Disease. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Moderately to Severely Active Crohns Disease. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Moderately to Severely Active Crohns Disease
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06819891 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 90 locations. Find a study site near you:

Clinical Research Site

Lancaster, California 93534 - United States

Status: RECRUITING

Clinical Research Site

Santa Clarita, California 91355 - United States

Status: RECRUITING

Clinical Research Site

Colorado Springs, Colorado 80907 - United States

Status: RECRUITING

Clinical Research Site

Doral, Florida 33173 - United States

Status: RECRUITING

Clinical Research Site

Miami Beach, Florida 33141 - United States

Status: RECRUITING

Clinical Research Site

Miami, Florida 33033 - United States

Status: RECRUITING

Clinical Research Site

Miami, Florida 33155 - United States

Status: RECRUITING

Clinical Research Site

Miramar, Florida 33027 - United States

Status: RECRUITING

Clinical Research Site

Orlando, Florida 32825 - United States

Status: RECRUITING

Clinical Research Site

Port Orange, Florida 32127 - United States

Status: RECRUITING

And 80 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Moderately to Severely Active Crohns Disease:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships